Identification of Potential α-Glucosidase Inhibitors from American Ginseng Processed Products by UHPLC-Q-Orbitrap/MS and Molecular Docking
Authors:
- 18 June 2024
- journal article
- research article
- Published by Springer Nature in Food Biophysics
- Vol. 19 (3) , 688-700
Abstract
No abstract availableKeywords
Funding Information
- The National Natural Science Foundation of China (81903778)
- the Science and Technology Development Plan Project of Jilin Province (20200201196JC)
- The China National Traditional Chinese Medicine Standardization Project (ZYBZH-Y-JL-25)
This publication has 27 references indexed in Scilit:
- Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021The Lancet, 2023
- Identification of α-glucosidase inhibitors from Mulberry using UF-UPLC-QTOF-MS/MS and molecular dockingJournal of Functional Foods, 2023
- An overview on the role of bioactive α-glucosidase inhibitors in ameliorating diabetic complicationsFood and Chemical Toxicology, 2020
- Steroidal saponins and sapogenins from fenugreek and their inhibitory activity against α-glucosidaseSteroids, 2020
- Therapeutic potential of ginsenosides on diabetes: From hypoglycemic mechanism to clinical trialsJournal of Functional Foods, 2020
- Multicomponent assessment and ginsenoside conversions of Panax quinquefolium L. roots before and after steaming by HPLC-MSnJournal of Ginseng Research, 2019
- Ginsenoside Re Ameliorates Brain Insulin Resistance and Cognitive Dysfunction in High Fat Diet-Induced C57BL/6 MiceJournal of Agricultural and Food Chemistry, 2017
- Distinct urine metabolome after Asian ginseng and American ginseng intervention based on GC-MS metabolomics approachScientific Reports, 2016
- Chemical analysis of Panax quinquefolius (North American ginseng): A reviewJournal of Chromatography A, 2015
- Ginsenosides from American ginseng: Chemical and pharmacological diversityPhytochemistry, 2011